Chat with us, powered by LiveChat
BUY TICKETS

SAVE $926 BY JAN. 13

PMWC 2026 · Track 1

Emerging Therapeutics From engineered cells to therapies that deliver

For leaders and operators turning breakthrough modalities into real patient impact.

Meet & Network with Tx Leaders: See all Tx leaders
Co-hosted by Stanford, UCSF & Yale Cell Therapy · Immunotherapy · ADCs · RNA/Stem Cells · Gene Editing
Engineered cell-based therapies

CAR-T, TILs, NK, allogeneic + in vivo approaches, focused on what’s translating.

Immuno-oncology & targeted Tx

Checkpoint 2.0, vaccines, ADCs, combos, resistance, and biomarker gates.

RNA, stem cells & gene-based Tx

mRNA/siRNA/ASOs, in vivo gene therapy, iPSC platforms, and patient stratification.

PMWC audience and speakers

Why: Track Focus

The bottleneck isn’t “more modalities.” It’s translation: manufacturability, delivery, safety, and clinical proof that holds up.

  • From breakthrough to scalable CMC, automation, supply chain, and repeatable manufacturing.
  • From response to durability persistence, safety, resistance, and smart combinations.
  • From patient promise to patient selection biomarkers, stratification, and clinical decision points.

Who: Attends

Biopharma R&D & Therapeutics Leaders Cell Therapy / Gene Editing / RNA Platform Teams Clinical Development & Translational Medicine Oncology & Immunology KOLs Manufacturing / CMC / Process Automation Regulatory & IP / BD Decision Makers Investors & Founders Building Therapeutics

Therapeutics orgs in the room

Key challenges we help you solve

Manufacturing & scale

Automation, CMC, consistency, cost, and supply chain realities.

Solid tumor delivery

TME barriers, trafficking, persistence, and on-target/off-tumor risk.

Safety & durability

Control, conditioning, cytokine risk, and long-term response.

Biomarkers & stratification

Who benefits, how to pick combos, and when to switch.

Trial ops in the real world

Site readiness, logistics, and operationalizing complex protocols.

Regulatory + IP realities

Evidence expectations, evolving standards, and defensible strategy.

Therapeutics leaders

Track 1 speakers · March 4–6, 2026

Mar 4 — Next-Gen Tx

Mar 5 — Immunotherapies & Targeted Therapies

Mar 6 — Next-Gen Tx

Build therapies that actually translate

Register for the content, sponsor for the meetings.

Track 1: Emerging Therapeutics
Colleague Feedback — PMWC 2026

There is no other event with such a lineup of leaders in their field. My annual MUST event since 2013!

Thomas Wilckens, MD, VP Precision Medicine & Precision Health, ECTT

You truly have an all-star, world-class crew lined up!

Alexis Hall, PhD, Professor

I am thrilled to hear about the impressive 2026 lineup of speakers and the engaging topics planned for the conference.

Amanda Acerbi, PharmD, Precision Medicine Global Director, Janssen (J&J)

PMWC is a landmark event, a real tour de force in precision medicine!

Mehme Hachem, PhD, Sr. Bioinformatician, IO / ML, Université de Montréal

The conference is excellent, and the 2026 speaker lineup is truly stellar — it seems to get stronger every year.

Mike Zack, MD, PhD, MPH, CEO & Co‑Founder, PGxAI

I just registered, fantastic lineup! Can't wait for this!

Thierry Giffon, PhD, Immunologist, Translational Scientific Leader

Congrats. This is an amazing rock star lineup.

Amanda Cashin, PhD, Bio Company Builder & Investor, Wing VC

The PMWC program and speaker lineup is one of the most impactful and thoughtfully curated conferences in healthcare today.

Tanmay Khilnani, Founder & Chief, Dept. of Medicine, University of Washington

I’ve spoken and had exhibitions in the past at PMWC — one of my favorite conferences of the year — and this 2026 year is extra impressive.

Tod Klingler, PhD, Co‑Founder & CEO, GeneLeap

Tal has done an amazing job developing the PMWC into the #1 premier precision medicine conference.

Trish Brown, SVP, Payer Relations and Reimbursement, GeneDx

Incredible line up! Great event you are putting on

Christina Zigliotto, Head of Generative AI & Machine Learning, Amazon AWS

What an impressive lineup.

I‑Chen Fong, PharmD, Ambulatory Care Pharmacist, Kaiser Permanente

Congratulations on the amazing speaker lineup this year. Wow!

Snehit Prabhu, PhD, Chief Data Scientist, Cancer Cell Therapy, Stanford Cancer Institute

PMWC 2025 was excellent, and the lineup sounds truly impressive!

Liat Dassa, PhD, Director of Program Planning, Biology & Computational Models, CytoReason

The line up has come together beautifully and quite impressively. Many people have mentioned how much they are looking forward to it.

Andrea Vuturo, Partner, Vuturo Group

Explore the PMWC 12 Program Tracks:

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JAN. 13TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required